From: "Jeffrey E." <[email protected]>

From: "Jeffrey E." <[email protected]> To: george church Subject: Re: Investment Protections Date: Sat, 11 Oct 2014 23:02:15 +0000 great .anytime you want it I be at martins from 12-6 On Sat, Oct 11, 2014 at 6:59 PM, george church < Sure. --George wrote: From: "Jeffrey E." <[email protected]> Date: Saturday, October 11, 2014 at 3:57 PM To: george church < > Subject: Re: FW: Investment Protections anyu chance you are around and availbale on mondayn in cambridge On Thu, Oct 2, 2014 at 7:13 AM, george church St- wrote: See the response from James below. Of the 76 pages, should I assume that, as with Mozart, every note is needed? —George From: James Clement Date: Wednesday, October 1, 2014 at 4:03 PM To: george church •c > Subject: Re: FW: Investment Protections Hi George, Glad to hear from you. Did your daughter have her baby yet? I hope all is well. As you know, we've been in a Seed Stage financing position since we began, receiving anywhere from $100,000 to $200,000 per year from angel investors. In 2014 we've taken in no funding. It was important to our early investor(s) to get a pro-rata (based on their capital accounts) share of our Net-Operating-Losses, so they could use such against their own taxes, which is why we favored a LLC structure. It was contemplated that at some point, probably when we had achieved some patentable IP, that wed need to restructure into a typical C corp with the usual layers of common and preferred shares, as generally required by a VC. Since many VCs demand a particular structure, we felt it best to wait until we had negotiated such a Series A round, before undergoing the expense of these changes. With this in mind, perhaps we can schedule a phone call in which we discuss Darren's recommendations and how you see things going in the near future. Please feel free to share the above information with him, and let me know how I can help you get comfortable with an investment in Androcyte LLC. As I had offered before, you're welcome to become a co- manager of the Company, if you'd like. I would value your assistance and guidance! Thanks, James James Clement, J.D., LL.M. CEO, Androcyte LLC & Betterhumans Inc. Supercentenarian Research Study U.S. Cell: EFTA00998421 On Wed, Oct I, 2014 at 1:04 PM, george church < > wrote: James, The following documents which contain exemplary protections that should be built into any financing by Georgarage, LLC: • Series 5 Preferred Stock Purchase Agreement, which includes o time limitations for subsequent financings in the same financing round o protective representations and warranties o closing conditions • Amended and Restated Articles of Incorporation, which include o dividend preferences o liquidation preferences o conversion rights o anti-dilution adjustments on conversion price o special voting as to different series or classes of securities • Sixth Amended and Restated Investor Rights Agreement, which includes o general restrictions on transfer o demand registration rights o piggy-back registration rights o S-3 registration rights o Rule 144 reporting obligations of the Company o preemptive rights/anti-dilution rights for new issuances of securities by the Company o Company financial reporting obligations and investor inspection rights • Fourth Amended and Restated Voting Agreement, which includes o voting rights for different series of securities with respect to electing directors o drag along obligations for investors to vote in favor of major transactions (i.e., sale of substantially all of the Company's assets or sale of all outstanding stock) approved by key holders (i.e., Georgarage, LLC) • Third Amended and Restated Right of First Refusal Agreement, which includes o in case of a investor's desire to sell his shares, a right of first refusal in favor of the Company and the other investors Regards, Darren Indyke DARREN K. INDYKE DARREN K. INDYKE, PLLC 575 Lexington Avenue, 4th Floor New York, New York 10022 Telephone: Telecopier: Mobile: email: ************************************************************************************* ********* The information contained in this communication is confidential, may be attorney-client privileged, and is intended only for the use of the addressee. It is the property of Darren K. Indyke, PLLC. Unauthorized use, disclosure or copying of this communication or any part thereof is strictly prohibited and may be unlawful. If you have received this communication in error, please notify us immediately by return e-mail, and destroy this communication and all copies thereof, including all attachments. Copyright of Darren K. Indyke, PLLC - C 2014 Darren K. Indyke, PLLC — All rights reserved. EFTA00998422 ************************************************************************************* ********** please note The information contained in this communication is confidential, may be attorney-client privileged, may constitute inside information, and is intended only for the use of the addressee. It is the property of JEE Unauthorized use, disclosure or copying of this communication or any part thereof is strictly prohibited and may be unlawful. If you have received this communication in error, please notify us immediately by return e-mail or by e-mail to [email protected], and destroy this communication and all copies thereof, including all attachments. copyright -all rights reserved please note The information contained in this communication is confidential, may be attorney-client privileged, may constitute inside information, and is intended only for the use of the addressee. It is the property of JEE Unauthorized use, disclosure or copying of this communication or any part thereof is strictly prohibited and may be unlawful. If you have received this communication in error, please notify us immediately by return e-mail or by e-mail to [email protected], and destroy this communication and all copies thereof, including all attachments. copyright -all rights reserved EFTA00998423